HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Baby-Care Sales Down With Second Talc Cancer Trial Underway

This article was originally published in The Rose Sheet

Executive Summary

A second trial examining an alleged link between perineal use of J&J's talcum-based powder products and ovarian cancer began April 11, following a February jury verdict in the same court that ordered the firm to pay $72m in damages to the family of an ovarian cancer casualty. J&J's baby-care performance weighed on overall results in the firm's first fiscal quarter, while OTC product sales continue to rebound.


Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts